Camas resident Douglas Tweet argues that IBR ridership projections rely on past data instead of actual C-TRAN usage, ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

In this week's Staff Favourites, we're showing off a few of our favourite finds from the past seven days, covering all the ...